Share
Share today's newsletter with a colleague and get credit if they sign up for SmartBrief.
Referral Count:
 
0

Story being shared
Pharmaron and AstraZeneca enter drug-discovery deal in China
AstraZeneca will collaborate with Pharmaron to accelerate drug discovery in China. The deal will boost AstraZeneca's 300-strong team in the country by adding "a few hundred" scientists, said Martin Mackay, president of global research and development. The agreement will cover treatments for respiratory, cardiovascular, gastrointestinal and infectious diseases, as well as inflammation, neuroscience and cancer, Mackay said.

Or we can send an email on your behalf
You must submit valid email addresses only. Use of email addresses is subject to terms of SmartBrief's privacy policy .